Publications by authors named "M I Milowsky"

Claim this Profile
A
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.
M D Galsky, J E Gschwend, M I Milowsky, M Schenker, B P Valderrama

Ann Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Rana R McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges, Matthew Milowsky

CA Cancer J Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling.
Michael S Sturdivant, Andrew S Truong, Mi Zhou, Elliott D Toomer, Wolfgang Beckabir, Matthew I Milowsky

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, Dimitra Rafailia Bakaloudi, Rafee Talukder, Matthew I Milowsky

Oncologist· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of renal mass biopsy on decision-making experience for clinical T1 renal masses.
Kathryn H Gessner, Allison M Deal, Amir Feinberg, Shannon Myers, Katherine Poulos, Matthew I Milowsky

J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis